Oncology nurses not adhering to safe handling guidelines of antineoplastic agents
the ONA take:
According to a new study funded by the National Institute for Occupational Safety and Health (NIOSH) and published online in the Journal of Occupational and Environmental Hygiene, researchers have found that healthcare workers do not always follow recommended safe handling practices for the administration of antineoplastic drugs in healthcare settings.
Of 2,100 oncology nurses and other healthcare personnel, 80% do not wear two pairs of chemotherapy gloves and 15% do not even wear a single pair during the administration of antineoplastic agents to patients. In addition, 42% do not always wear a nonabsorbent gown with closed front and tight-fitting cuffs. Of those surveyed, 12% report taking home potentially contaminated clothing and 4% report skin contact with an antineoplastic agent.
The researchers suggest that better communication surrounding the risks of not following the best practice recommendations put forth by authoritative safe handling guidelines. Healthcare workers and oncology nurses should be fully aware of the hazards associated with not following these guidelines and the precautionary measures that can be used to minimize exposure to antineoplastic agents.
Healthcare workers do not always follow recommended safe handling practices for antineoplastic drugs.
A new National Institute for Occupational Safety and Health (NIOSH) study, published online in the Journal of Occupational and Environmental Hygiene, found that recommended safe handling practices for workers who administer antineoplastic drugs in healthcare settings are not always followed. Results are derived from the 2011 Health and Safety Practices Survey of Healthcare Workers, the largest federally-sponsored survey of healthcare workers in the U.S., which addresses safety and health practices relative to use of hazardous chemicals.This paper presents findings on current administrative and engineering control practices, personal protective equipment (PPE), and barriers to using recommended PPE during administration of antineoplastic drugs by nearly 2,100 oncology nurses and other healthcare personnel who completed a module addressing antineoplastic drug administration.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|